Sugi Predict

Sugi Predict / Compounds / SCHEMBL5018461

SCHEMBL5018461

SCHEMBL5018461

CCOc1cc(NC(=O)[C@H](CCc2ccccc2)NC(=O)[C@@H](N)CC(=O)N(CCN)CCN)cc(Cl)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRNB2 P17787 1/20 0.37
▸ CHRNB4 P30926 1/20 0.37
▸ CHRNA3 P32297 1/20 0.37
▸ CHRNA4 P43681 1/20 0.37
▸ KLKB1 P03952 2/20 0.35
▸ CALCRL Q16602 1/20 0.35
▸ CTSC P53634 1/20 0.35
▸ METAP2 P50579 1/20 0.34
▸ MMP3 P08254 4/20 0.34
▸ LNPEP Q9UIQ6 2/20 0.34
▸ MMP1 P03956 1/20 0.34
▸ MMP2 P08253 1/20 0.34
▸ MMP12 P39900 1/20 0.34
▸ MMP13 P45452 1/20 0.34
▸ ERAP2 Q6P179 1/20 0.34
▸ S1PR2 O95136 2/20 0.34
▸ SIRT2 Q8IXJ6 1/20 0.34
▸ SIRT1 Q96EB6 1/20 0.34
▸ PSMB8 P28062 1/20 0.34
▸ PSMB5 P28074 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5018181 0.91 CALCRL (0.39) CHRNB2CHRNB4CHRNA3CHRNA4CALCRL
SCHEMBL5018422 0.88 CHRNB2 (0.37) CHRNB2CHRNB4CHRNA3CHRNA4KLKB1
SCHEMBL5018615 0.84 CHRNB2 (0.38) CHRNB2CHRNB4CHRNA3CHRNA4KLKB1
SCHEMBL5018378 0.84 CALCRL (0.39) CHRNB2CHRNB4CHRNA3CHRNA4CALCRL
Hydrochloric Acid SCHEMBL2748269 0.84 CHRNB2 (0.37) CHRNB2CHRNB4CHRNA3CHRNA4KLKB1
SCHEMBL5018174 0.83 METAP2 (0.49) METAP2
SCHEMBL5018356 0.83 HDAC4 (0.47) CALCRLMETAP2MMP3MMP2MMP12
SCHEMBL5018143 0.82 MMP2 (0.44) CHRNB2CHRNB4CHRNA3CHRNA4CALCRL
Hydrochloric Acid SCHEMBL2748013 0.81 MMP2 (0.44) CHRNB2CHRNB4CHRNA3CHRNA4CALCRL
SCHEMBL5018357 0.81 SMN1; SMN2 (0.39) CHRNB2CHRNB4CHRNA3CHRNA4CALCRL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178490-B2 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof REMPEX PHARMACEUTICALS, INC. (US) 2012-05-15 — — US disclosed
US-8178490-B2 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof REMPEX PHARMACEUTICALS, INC. (US) 2012-05-15 — — US disclosed
US-20100152098-A1 POLYBASIC BACTERIAL EFFLUX PUMP INHIBITORS AND THERAPEUTIC USES THEREOF MPEX PHARMACEUTICALS, INC. (US) 2010-06-17 — — US disclosed
US-20100152098-A1 POLYBASIC BACTERIAL EFFLUX PUMP INHIBITORS AND THERAPEUTIC USES THEREOF MPEX PHARMACEUTICALS, INC. (US) 2010-06-17 — — US disclosed
WO-2010054102-A2 POLYBASIC BACTERIAL EFFLUX PUMP INHIBITORS AND THERAPEUTIC USES THEREOF MPEX PHARMACEUTICALS, INC. (US) 2010-05-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152098-A1 POLYBASIC BACTERIAL EFFLUX PUMP INHIBITORS AND THERAPEUTIC USES THEREOF ABCB11, ABCB1, SLC47A1 CHRNB2 4860/4885CHRNB4 4858/4885CHRNA3 4883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.